Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration
New flagship facility provides hands-on access to Bio-Techne technologies, workflows and scientific expertise Regional hub will support researchers and organizations across the DACH and broader EMEA regions Center strengthens collaboration, training and innovation within Europe's life sciences community MINNEAPOLIS and DÜSSELDORF, Germany, Sept. 22, 2026 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:...
AIMD Expands A-LRYNGO, the World’s First AI-Guided Video Laryngoscope, to Global Markets
Dual Korean Government Recognition Advances AI-Guided Intubation Toward a New Standard in Airway Management SEOUL, South Korea, Sept. 22, 2026 /PRNewswire/ -- AIMD Inc., a Korean medical technology company specializing in AI-powered emergency care, announced the global expansion of A-LRYNGO™, the world's first AI-guided video laryngoscope with real-time automatic glottis recognition, as the company advances AI-guided airway management into...
From Next-Gen AI to Surgical Robots: IEEE Celebrates the Technical Innovators Shaping the Future
World's leading technology and engineering community unveils 2027 Technical Field Awards, recognizing achievements in medical robotics, wireless networks, digital privacy, power electronics, computing technology, and more PISCATAWAY, N.J., Sept. 22, 2026 /PRNewswire/ -- Celebrating innovations ranging from life-saving surgical robots to next-generation Wi-Fi and electric vehicles, IEEE — the world's largest technical...
China takes decisive action to advance global development
BEIJING, Sept. 22, 2026 /PRNewswire/ -- A report from People's Daily Under the framework of the Global Development Initiative (GDI), China has worked with various parties to launch more than 2,000 cooperative projects, directly benefiting communities in more than 120 countries. These efforts are providing vital momentum toward achieving the goals of the United Nations 2030 Agenda for...
Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders
Clinical Milestone Expands Development of Paxalisib Beyond Oncology and Triggers $2 Million Payment to Kazia SYDNEY, Sept. 22, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced that Sovargen Co., Ltd., a biotechnology...
Multiple Sacituzumab Tirumotecan (sac-TMT) Studies Selected as LBAs at ESMO 2026, OptiTROP-Lung04 and OptiTROP-Lung06 to be Presented in the Lung Cancer Session
CHENGDU, China, Sept. 22, 2026 /PRNewswire/ -- The 2026 European Society for Medical Oncology (ESMO) Congress will be held in Madrid, Spain, from October 23 to 27. Multiple Phase III clinical studies of the TROP2 ADC sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) developed by Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd....
NUH ENDOCRINOLOGY TEAM SHOWCASES END-TO-END CARE MODEL THAT PROTECTS HOSPITALISED PATIENTS WITH DIABETES MELLITUS (DM) ACROSS THEIR CARE JOURNEY
NUH's Inpatient DM management team highlights how safe prescribing is strengthened through proactive monitoring, rapid intervention and coordinated care transitions. SINGAPORE, Sept. 21, 2026 /PRNewswire/ -- Newer diabetes treatments are transforming care, helping patients not only manage their blood sugar levels but also protect their hearts and kidneys while reducing the...
70 Hong Kong Medical and Nursing Students Explore Children’s Healthcare in Conflict at MSF Taster Day
HONG KONG, Sept. 22, 2026 /PRNewswire/ -- Médecins Sans Frontières (MSF) Hong Kong held an "MSF Taster Day" workshop at its office last Saturday (19 September), attended by nearly 70 first- to third-year medical and nursing students from local universities. Guided by MSF aid workers, participants experienced practical clinical skills used in MSF projects and learned about the...
BoomRay Enters Exclusive Global License Agreement with Novartis for a Novel Radioligand Therapy Asset
SUZHOU, China, Sept. 22, 2026 /PRNewswire/ -- Boomray Pharmaceuticals Co., Ltd. ("BoomRay"), a clinical-stage biotechnology company pioneering innovative radioligand therapies (RLTs) for precision oncology diagnostics and therapeutics, today announced that it has entered into an exclusive global license agreement with Novartis Pharma AG ("Novartis") for an undisclosed preclinical RLT asset. The agreement brings together BoomRay's discovery and development...
Bestzyme Launches World’s First Dedicated, Automated Smart Production Line for Sweet Proteins in Jinan
JINAN, China, Sept. 22, 2026 /PRNewswire/ -- Bestzyme, a synthetic biology company under GenScript Biotech, today announced the completion of the world's first dedicated, automated smart production line for sweet proteins at its Jinan facility. This milestone marks the first full-chain integration of R&D, mass production, and application for sweet proteins globally, addressing the food and beverage industry's long-standing...
